These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 12712840)

  • 1. [Bioavailability and its significance in pharmacotherapy].
    Wiela-Hojeńska A; Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 2003 Jan; 14(79):89-93. PubMed ID: 12712840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Absorption and biological availability of drugs].
    Uribe M
    Rev Gastroenterol Mex; 1977; 42(1):2-8. PubMed ID: 616972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biologic availability and "1st pass" effect of drugs].
    Rietbrock N; Keller F
    Fortschr Med; 1977 Jul; 95(28):1765-6, 1774-80. PubMed ID: 914146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique.
    von Richter O; Greiner B; Fromm MF; Fraser R; Omari T; Barclay ML; Dent J; Somogyi AA; Eichelbaum M
    Clin Pharmacol Ther; 2001 Sep; 70(3):217-27. PubMed ID: 11557909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The bioavailability of orally administered drugs with special regard to the liver as a filter for foreign matter].
    Raaflaub J
    Schweiz Med Wochenschr; 1980 Mar; 110(10):354-62. PubMed ID: 7394464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a novel in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability.
    Lau YY; Chen YH; Liu TT; Li C; Cui X; White RE; Cheng KC
    Drug Metab Dispos; 2004 Sep; 32(9):937-42. PubMed ID: 15319334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug dosing in chronic hepatic disease (author's transl)].
    Gugler R; Eichelbaum M
    Leber Magen Darm; 1981 Apr; 11(2):81-7. PubMed ID: 7015045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-pass elimination. Basic concepts and clinical consequences.
    Pond SM; Tozer TN
    Clin Pharmacokinet; 1984; 9(1):1-25. PubMed ID: 6362950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological availability].
    Weber E; Gundert-Remy U
    Arzneimittelforschung; 1975 Jul; 25(7a):1158-62. PubMed ID: 1242346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism.
    Tannergren C; Engman H; Knutson L; Hedeland M; Bondesson U; Lennernäs H
    Clin Pharmacol Ther; 2004 Apr; 75(4):298-309. PubMed ID: 15060508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methodological approach to the measure of the bioavailability of drugs in man (author's transl)].
    Lesne M
    J Pharm Belg; 1976; 31(1):5-24. PubMed ID: 768445
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential clinical significance of differences in bioavailability.
    Hosp Formul; 1976 Sep; 11(9):484, 487-8. PubMed ID: 10316482
    [No Abstract]   [Full Text] [Related]  

  • 16. Importance of biopharmaceutics and pharmacokinetics in clinical medicine.
    Cabana BE
    Arzneimittelforschung; 1976; 26(1A):151-8. PubMed ID: 947194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective first-pass metabolism of verapamil in the small intestine and liver in rats.
    Hanada K; Ikemi Y; Kukita K; Mihara K; Ogata H
    Drug Metab Dispos; 2008 Oct; 36(10):2037-42. PubMed ID: 18617604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model.
    Coelingh Bennink HJ; Heegaard AM; Visser M; Holinka CF; Christiansen C
    Climacteric; 2008; 11 Suppl 1():2-14. PubMed ID: 18464016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey.
    Ward KW; Stelman GJ; Morgan JA; Zeigler KS; Azzarano LM; Kehler JR; McSurdy-Freed JE; Proksch JW; Smith BR
    Drug Metab Dispos; 2004 Feb; 32(2):172-7. PubMed ID: 14744938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extremely low bioavailability of magnesium lithospermate B, an active component from Salvia miltiorrhiza, in rat.
    Zhang Y; Akao T; Nakamura N; Duan CL; Hattori M; Yang XW; Liu JX
    Planta Med; 2004 Feb; 70(2):138-42. PubMed ID: 14994191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.